Eton Pharmaceuticals (ETON) Competitor Comparison
We are evaluating the key criteria listed to compare Eton Pharmaceuticals (ETON) against its competitors in the Biotechnology industry.
Market Capitalization
256 / 368Gross Profits
93 / 278Total Revenue
140 / 300EBITDA
30 / 337Free Cashflow
34 / 352Quick Ratio
273 / 357Earnings per Share
60 / 359Dividend yield
0 / 6Total Cash
297 / 358Performance 3 years
66 / 368Performance 5 years
99 / 368Performance 10 years
87 / 368Linearity 3 years
332 / 368Linearity 5 years
159 / 368Linearity 10 years
123 / 368Total Rank
120 / 368Dividend Rank
123 / 368Valuation Rank
143 / 368Piotroski Rank
277 / 368Muliplier Rank
340 / 368Dividend Rank - ETON ranking 123 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.